Health & FitnessFitness F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder By NYtimes - August 12, 2021 0 148 Share Facebook Twitter Google+ Pinterest WhatsApp Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar. Source : Nytimes